Picotamide
![]() | |
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names |
| ATC code | B01AC03 (WHO) |
| Identifiers | |
| |
| PubChem (CID) | 4814 |
| ChemSpider |
4649 |
| UNII |
654G2VCI4Q |
| ECHA InfoCard | 100.046.572 |
| Chemical and physical data | |
| Formula | C21H20N4O3 |
| Molar mass | 376.409 g/mol |
| 3D model (Jmol) | Interactive image |
| |
| |
| (verify) | |
Picotamide is a platelet aggregation inhibitor. It works as a thromboxane synthase inhibitor and a thromboxane receptor inhibitor, the latter by modifying cellular responses to activation of the thromboxane receptor.[1]
References
- ↑ Ratti, S; Quarato, P; Casagrande, C; Fumagalli, R; Corsini, A (1998). "Picotamide, an antithromboxane agent, inhibits the migration and proliferation of arterial myocytes". European Journal of Pharmacology. 355 (1): 77–83. doi:10.1016/S0014-2999(98)00467-1. PMID 9754941.
External links
- Andrea Celestini and Francesco Violi: A review of picotamide in the reduction of cardiovascular events in diabetic patients (PubMed)
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
